1. A method for culturing a human neural stem cell, comprising the step of providing a human neural stem cell that has been determined to express CD56 and to not express TRA-1-60 and TRA-1-81, and culturing the human stem cell in a medium containing LIF (Leukemia Inhibitory Factor).